D. Loukopoulos

发表

The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation

D. Farmakis, M. Angastiniotis, A. Eleftheriou, 2021, Hemoglobin.

Haematological Aspects of Antenatal Diagnosis for Thalassaemia in Britain

P. Ioannou, B. Modell, M. Angastiniotis, 1980, British journal of haematology.

Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease.

S. Bonovas, G. Paterakis, A. Tsantes, 2004, Respiratory medicine.

HbO-Arab mutation originated in the Pomak population of Greek Thrace.

E. Dermitzakis, D. Petridis, Georgios Xanthopoulidis, 2005, Haematologica.

Modulating the oxygen affinity of human fetal haemoglobin with synthetic allosteric modulators

I. Papassotiriou, D. Abraham, M. Marden, 1998, British journal of haematology.

No evidence of frequent association of the JAK2 V617F mutation with acute myocardial infarction in young patients

L. Rallidis, I. Dahabreh, K. Zoi, 2009, Leukemia.

Hairy cell leukemia and myelomatosis: chance association or clinical manifestations of the same B-cell disease spectrum.

P. Fessas, D. Loukopoulos, C. Costello, 1981, Blood.

Hypereosinophilic syndrome: another face of janus?

S. Giannouli, I. Dahabreh, K. Zoi, 2008, Leukemia research.

Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1).

K. Konstantopoulos, V. Kalotychou, M. Karagiorga, 2000, Haematologica.

Thalassaemia in Cyprus

G. Stamatoyannopoulos, K. Sofroniadou, D. Loukopoulos, 1973, British medical journal.

Combined therapy with deferiprone and desferrioxamine in thalassemia major.

D. Loukopoulos, 2005, Haematologica.

Haemoglobin Nicosia. AN α‐CHAIN VARIANT AND ITS COMBINATION WITH β‐THALASSAEMIA

G. Stamatoyannopoulos, C. Fessas, P. Fessas, 1965 .

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia.

S. Giannouli, I. Dahabreh, K. Zoi, 2009, Leukemia research.

Lymphocyte Subpopulations and Interleukin Levels in High-Risk Melanoma Patients Treated With High-Dose Interferon A-2B

M. Mihm, H. Gogas, G. Paterakis, 2002, American journal of clinical oncology.

Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon

H. Gogas, D. Pectasides, A. Polyzos, 2002, British Journal of Cancer.

Erythropoietin levels and microcytosis in heterozygous beta-thalassaemia.

K. Konstantopoulos, V. Alevizou-Terzaki, D. Loukopoulos, 1997, Acta haematologica.

Hairy Cell Leukemia: Residual Splenic Disease After Successful α2b-Interferon Therapy

C. Kittas, G. Pangalis, P. Fessas, 1992 .

DETECTION OF HISTOCOMPATIBILITY ANTIGENS HL-A1, 2, 5, AND 7 ON LEUKOCYTES BY A SIMPLIFIED COMPLEMENT-FIXATION METHOD

J. Dausset, J. Colombani, D. Loukopoulos, 1969, Transplantation.

Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production

S. Bonovas, A. Tsantes, S. Tassiopoulos, 2003, European Journal of Clinical Pharmacology.